PPLPHARMA.NSPPLPHARMA.NSNSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+113.0%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+113.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
9.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$36.12B+595.0%
2024$5.20B+1544.6%
2023$-359.80M-109.6%
2022$3.74B-83.4%
2021$22.46B-